Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Fassett

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Experimental Physiology|July 26, 2011
The uraemic milieu, the ubiquitin-proteasome pathway and the endothelial cell: a pathway to dysfunctionRobert G Fassett
Clinical Interventions in Aging|January 31, 2014
Current and emerging treatment options for the elderly patient with chronic kidney diseaseRobert G Fassett
Kidney International|October 7, 2011
Antioxidant therapy in hemodialysis patients: a systematic reviewJeff S Coombes, Robert G Fassett
The Medical Journal of Australia|February 24, 2006
Morning report: an Australian experienceRobert G Fassett, Steven J Bollipo
BMJ (Clinical Research Ed.)|March 21, 2013
Statins in acute kidney injury: friend or foe?Robert G Fassett, Jeff S Coombes
Molecules (Basel, Switzerland)|February 22, 2012
Astaxanthin in cardiovascular health and diseaseRobert G Fassett, Jeff S Coombes
Future Cardiology|August 7, 2009
Astaxanthin, oxidative stress, inflammation and cardiovascular diseaseRobert G Fassett, Jeff S Coombes
Marine Drugs|May 11, 2011
Astaxanthin: a potential therapeutic agent in cardiovascular diseaseRobert G Fassett, Jeff S Coombes
Kidney International|March 22, 2013
Targets, trends, excesses, and deficiencies: refocusing clinical investigation to improve patient outcomesAdeera Levin, William Lancashire, Robert G Fassett
The Medical Journal of Australia|January 22, 2013
Improving effectiveness of clinical medicine: the need for better translation of science into practiceRobert G Fassett, Bill Lancashire, Anne Rasmussen
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Experimental Physiology|July 26, 2011
The uraemic milieu, the ubiquitin-proteasome pathway and the endothelial cell: a pathway to dysfunctionRobert G Fassett
Clinical Interventions in Aging|January 31, 2014
Current and emerging treatment options for the elderly patient with chronic kidney diseaseRobert G Fassett
Kidney International|October 7, 2011
Antioxidant therapy in hemodialysis patients: a systematic reviewJeff S Coombes, Robert G Fassett
The Medical Journal of Australia|February 24, 2006
Morning report: an Australian experienceRobert G Fassett, Steven J Bollipo
BMJ (Clinical Research Ed.)|March 21, 2013
Statins in acute kidney injury: friend or foe?Robert G Fassett, Jeff S Coombes
Molecules (Basel, Switzerland)|February 22, 2012
Astaxanthin in cardiovascular health and diseaseRobert G Fassett, Jeff S Coombes
Future Cardiology|August 7, 2009
Astaxanthin, oxidative stress, inflammation and cardiovascular diseaseRobert G Fassett, Jeff S Coombes
Marine Drugs|May 11, 2011
Astaxanthin: a potential therapeutic agent in cardiovascular diseaseRobert G Fassett, Jeff S Coombes
Kidney International|March 22, 2013
Targets, trends, excesses, and deficiencies: refocusing clinical investigation to improve patient outcomesAdeera Levin, William Lancashire, Robert G Fassett
The Medical Journal of Australia|January 22, 2013
Improving effectiveness of clinical medicine: the need for better translation of science into practiceRobert G Fassett, Bill Lancashire, Anne Rasmussen
Pageof 12